NO20070187L - Oralt desintegrerende farmasoytisk preparat omfattende risperidon - Google Patents

Oralt desintegrerende farmasoytisk preparat omfattende risperidon

Info

Publication number
NO20070187L
NO20070187L NO20070187A NO20070187A NO20070187L NO 20070187 L NO20070187 L NO 20070187L NO 20070187 A NO20070187 A NO 20070187A NO 20070187 A NO20070187 A NO 20070187A NO 20070187 L NO20070187 L NO 20070187L
Authority
NO
Norway
Prior art keywords
risperidone
pharmaceutical composition
orally disintegrating
disintegrating pharmaceutical
orally
Prior art date
Application number
NO20070187A
Other languages
English (en)
Inventor
Vesna Kroselj
Tadeja Rajer
Marija Rangus
Jozica Gustin
Original Assignee
Krka Tovarna Zdravil Dd Novo M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil Dd Novo M filed Critical Krka Tovarna Zdravil Dd Novo M
Publication of NO20070187L publication Critical patent/NO20070187L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det er beskrevet oralt desintegrerende farmasøytiske preparater inneholdende primært risperidon og polymetakrylat og en granuleringsfremgangsmåte for å oppnå disse.
NO20070187A 2004-06-15 2007-01-11 Oralt desintegrerende farmasoytisk preparat omfattende risperidon NO20070187L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004028940A DE102004028940A1 (de) 2004-06-15 2004-06-15 Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
PCT/EP2005/006375 WO2005123084A1 (en) 2004-06-15 2005-06-14 Orally disintegrating pharmaceutical composition comprising risperidone

Publications (1)

Publication Number Publication Date
NO20070187L true NO20070187L (no) 2007-03-02

Family

ID=34971693

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070187A NO20070187L (no) 2004-06-15 2007-01-11 Oralt desintegrerende farmasoytisk preparat omfattende risperidon

Country Status (13)

Country Link
EP (1) EP1768673B1 (no)
AT (1) ATE402706T1 (no)
DE (2) DE102004028940A1 (no)
EA (1) EA010178B1 (no)
ES (1) ES2311230T3 (no)
HR (1) HRP20080452T3 (no)
NO (1) NO20070187L (no)
PL (1) PL1768673T3 (no)
PT (1) PT1768673E (no)
RS (1) RS50609B (no)
SI (1) SI1768673T1 (no)
UA (1) UA87692C2 (no)
WO (1) WO2005123084A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
JP5275815B2 (ja) * 2006-12-26 2013-08-28 塩野義製薬株式会社 リスペリドンを含有する口腔内崩壊錠剤および苦味抑制製剤
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
WO2008152729A1 (ja) * 2007-06-15 2008-12-18 Teikokumedix Co., Ltd. リスペリドンを含むゼリー状の医薬組成物
CN101485636B (zh) * 2008-01-14 2010-12-22 齐鲁制药有限公司 利培酮口腔崩解片及其制备方法
WO2013095314A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising risperidone
WO2013100876A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Risperidone formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0910345B1 (en) * 1996-06-17 2002-02-13 Janssen Pharmaceutica N.V. Biconvex rapidly disintegrating dosage forms
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
CN1819819B (zh) * 2003-05-07 2011-03-09 株式会社三养社 用于制备速熔片的高度可塑性颗粒
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone

Also Published As

Publication number Publication date
WO2005123084A1 (en) 2005-12-29
RS50609B (sr) 2010-06-30
ATE402706T1 (de) 2008-08-15
EA200700023A1 (ru) 2007-06-29
PT1768673E (pt) 2008-10-21
DE102004028940A1 (de) 2006-01-12
UA87692C2 (ru) 2009-08-10
PL1768673T3 (pl) 2009-01-30
DE602005008607D1 (de) 2008-09-11
EA010178B1 (ru) 2008-06-30
SI1768673T1 (sl) 2008-12-31
HRP20080452T3 (hr) 2008-10-31
EP1768673B1 (en) 2008-07-30
ES2311230T3 (es) 2009-02-01
EP1768673A1 (en) 2007-04-04

Similar Documents

Publication Publication Date Title
MY157661A (en) Bendamustine pharmaceutical compositions
BE2014C011I2 (fr) Administration d'inhibiteurs de dipeptidyl peptidase
BRPI0511900A (pt) composições farmacêuticas
LU92326I2 (fr) Canakinumab et ses dérivés pharmaceutiquement acceptables (ILARIS)
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
ATE528989T1 (de) Kristalline feste rasagilin-base
CL2009000882A1 (es) Un compuesto n-(4-cloro-3-(piridin-2-il)fenil)-4-(2-hidroxi-2-metilpropilsulfonil)-2-metilbenzamida, inhibidor de la via de señalización hedgehog; composición farmacéutica que comprende a dicho compuesto; y su uso para tratar el cancer.
FR2883179B1 (fr) Comprime enrobe
MEP18208A (en) Immune response modifier foam formulations
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
MX2009001294A (es) Granulo y tableta que se desintegra por vía oral que comprende oxicodona.
UY31484A1 (es) Piperidinas heteroaril-sustituidas
ZA200702418B (en) Taste-masking Pharmaceutical compositions
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
GEP20125458B (en) Matrix metalloproteinase inhibitors
DE602006006536D1 (de) Trockene Aripiprazolformulierungen
ITFI20050041A1 (it) Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
PL1768673T3 (pl) Kompozycja farmaceutyczna rozpadająca się w ustach obejmująca risperidon
IL191992A0 (en) Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
MX2009005804A (es) Composicion farmaceutica de memantina.
IL198446A0 (en) Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
ATE415156T1 (de) 4-hydroxytamoxifengel-formulierungen
WO2006116556A3 (en) Composition comprising proton pump inhibitor and buffer
IS7196A (is) Ramipríl lyfjasamsetningar

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application